Reckitt Benckiser Looks Overseas To Double Adams’ Revenue
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser should meet its goal of doubling Adams Respiratory Therapeutics' revenues by launching the firms' OTC cough and congestion products overseas and introducing new products being developed by Adams in the United States, analysts and Reckitt executives say
You may also be interested in...
Citizen Petitions Are No Place To Request Enforcement Action - FDA
Citizen petitions are not the proper forum to prompt FDA to enforcement activity, the agency says
Reckitt Benckiser Is Focus Of Acquisition Speculation In Personal Care
As consumer products merger and acquisition activity revives, analysts are speculating about which players in the personal-care arena may be winding up for deals, with UK-based Reckitt Benckiser considered a likely suspect
Reckitt Benckiser Tops Acquisition Speculation In Personal Care
As consumer products merger and acquisition activity revives, analysts are speculating which players in the personal care arena may be winding up for deals, with U.K.-based Reckitt Benckiser named a likely suspect